BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 22710160)

  • 1. BMP signaling in vascular diseases.
    Cai J; Pardali E; Sánchez-Duffhues G; ten Dijke P
    FEBS Lett; 2012 Jul; 586(14):1993-2002. PubMed ID: 22710160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta signaling in vascular biology and dysfunction.
    Goumans MJ; Liu Z; ten Dijke P
    Cell Res; 2009 Jan; 19(1):116-27. PubMed ID: 19114994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergence and convergence of TGF-beta/BMP signaling.
    Miyazono K; Kusanagi K; Inoue H
    J Cell Physiol; 2001 Jun; 187(3):265-76. PubMed ID: 11319750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of bone morphogenetic proteins in angiogenesis.
    David L; Feige JJ; Bailly S
    Cytokine Growth Factor Rev; 2009 Jun; 20(3):203-12. PubMed ID: 19502096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in BMP receptor signaling.
    Sieber C; Kopf J; Hiepen C; Knaus P
    Cytokine Growth Factor Rev; 2009; 20(5-6):343-55. PubMed ID: 19897402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of BMPs in endothelial cell function and dysfunction.
    Dyer LA; Pi X; Patterson C
    Trends Endocrinol Metab; 2014 Sep; 25(9):472-80. PubMed ID: 24908616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk.
    Miyazono K; Maeda S; Imamura T
    Cytokine Growth Factor Rev; 2005 Jun; 16(3):251-63. PubMed ID: 15871923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
    Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
    BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The unique activity of bone morphogenetic proteins in bone: a critical role of the Smad signaling pathway.
    Katagiri T; Tsukamoto S
    Biol Chem; 2013 Jun; 394(6):703-14. PubMed ID: 23324379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-betas and vascular disorders.
    Bobik A
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1712-20. PubMed ID: 16675726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic proteins and growth differentiation factors as drug targets in cardiovascular and metabolic disease.
    Tobin JF; Celeste AJ
    Drug Discov Today; 2006 May; 11(9-10):405-11. PubMed ID: 16635802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
    Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
    Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes.
    Herpin A; Cunningham C
    FEBS J; 2007 Jun; 274(12):2977-85. PubMed ID: 17521337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein (BMP) family, SMAD signaling and Id helix-loop-helix proteins in the vasculature: the continuous mystery of BMPs pleotropic effects.
    Abe J
    J Mol Cell Cardiol; 2006 Jul; 41(1):4-7. PubMed ID: 16762360
    [No Abstract]   [Full Text] [Related]  

  • 15. Localization of STRO-1, BMP-2/-3/-7, BMP receptors and phosphorylated Smad-1 during the formation of mouse periodontium.
    Kémoun P; Laurencin-Dalicieux S; Rue J; Vaysse F; Roméas A; Arzate H; Conte-Auriol F; Farges JC; Salles JP; Brunel G
    Tissue Cell; 2007 Aug; 39(4):257-66. PubMed ID: 17662325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
    Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
    N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic protein receptor signal transduction in human disease.
    Gomez-Puerto MC; Iyengar PV; García de Vinuesa A; Ten Dijke P; Sanchez-Duffhues G
    J Pathol; 2019 Jan; 247(1):9-20. PubMed ID: 30246251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP signaling regulates PGC numbers and motility in organ culture.
    Dudley BM; Runyan C; Takeuchi Y; Schaible K; Molyneaux K
    Mech Dev; 2007 Jan; 124(1):68-77. PubMed ID: 17112707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
    de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
    J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.